Market revenue in 2023 | USD 545.4 million |
Market revenue in 2030 | USD 574.3 million |
Growth rate | 0.7% (CAGR from 2023 to 2030) |
Largest segment | Soil-transmitted helminthiases |
Fastest growing segment | Chagas disease |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne Trematode Infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African Trypanosomiasis (sleeping sickness), Soil-transmitted Helminthiases, Onchocerciasis, Schistosomiasis, Scabies and Other Ecoparasites, Snakebite Envenoming, Leishmaniases |
Key market players worldwide | Roche, Abbott Laboratories, Thermo Fisher Scientific Inc, Eurobio-Scientific, Omega Laboratories, Avacta Group PLC, Oscar Health Inc Class A, ZeptoMetrix, InBios, DiaSys Diagnostic Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neglected tropical diseases diagnosis market will help companies and investors design strategic landscapes.
Soil-transmitted helminthiases was the largest segment with a revenue share of 10.14% in 2023. Horizon Databook has segmented the Europe neglected tropical diseases diagnosis market based on dengue, chikungunya, rabies, leprosy, buruli ulcer, yaws, lymphatic filariasis, taeniasis/cysticercosis, foodborne trematode infections, echinococcosis, chagas disease, dracunculiasis, human african trypanosomiasis (sleeping sickness), soil-transmitted helminthiases, onchocerciasis, schistosomiasis, scabies and other ecoparasites, snakebite envenoming, leishmaniases covering the revenue growth of each sub-segment from 2018 to 2030.
According to WHO data in 2017, various measures were taken for controlling and eliminating different NTDs in Europe. The entire region has achieved global target for leprosy elimination, accounting for less than 1 million cases.
However, increasing prevalence of leprosy is anticipated to boost the market over the forecast period. Increased urbanization, rapid globalization, and climate changes are supplementary factors responsible for market growth in European region.
The WHO Europe monitors and supports controlling invasive vectors and re-emerging mosquito-borne diseases. Moreover, according to data published in Springer, in 2018, specific treatments and diagnoses are scarcely available in many European countries, increasing growing opportunities in the market over the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe neglected tropical diseases diagnosis market , including forecasts for subscribers. This continent databook contains high-level insights into Europe neglected tropical diseases diagnosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account